[go: up one dir, main page]

EE05587B1 - Meetod kollageenk„sna valmistamiseks - Google Patents

Meetod kollageenk„sna valmistamiseks

Info

Publication number
EE05587B1
EE05587B1 EEP200300349A EEP200300349A EE05587B1 EE 05587 B1 EE05587 B1 EE 05587B1 EE P200300349 A EEP200300349 A EE P200300349A EE P200300349 A EEP200300349 A EE P200300349A EE 05587 B1 EE05587 B1 EE 05587B1
Authority
EE
Estonia
Prior art keywords
making collagen
collagen
making
Prior art date
Application number
EEP200300349A
Other languages
English (en)
Estonian (et)
Inventor
Schaufler Alfred
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of EE200300349A publication Critical patent/EE200300349A/xx
Publication of EE05587B1 publication Critical patent/EE05587B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/36—Surgical swabs, e.g. for absorbency or packing body cavities during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A61F2013/00472—Plasters use haemostatic with chemical means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Medicinal Preparation (AREA)
EEP200300349A 2001-01-25 2002-01-25 Meetod kollageenk„sna valmistamiseks EE05587B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200100135 2001-01-25
DKPA200100235 2001-02-13
PCT/IB2002/001452 WO2002070594A2 (en) 2001-01-25 2002-01-25 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge

Publications (2)

Publication Number Publication Date
EE200300349A EE200300349A (et) 2003-10-15
EE05587B1 true EE05587B1 (et) 2012-10-15

Family

ID=26068956

Family Applications (3)

Application Number Title Priority Date Filing Date
EEP200300348A EE05678B1 (et) 2001-01-25 2002-01-25 Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine
EEP200300349A EE05587B1 (et) 2001-01-25 2002-01-25 Meetod kollageenk„sna valmistamiseks
EEP200300341A EE05685B1 (et) 2001-01-25 2002-01-25 Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EEP200300348A EE05678B1 (et) 2001-01-25 2002-01-25 Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP200300341A EE05685B1 (et) 2001-01-25 2002-01-25 Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga

Country Status (36)

Country Link
EP (4) EP1343542B1 (xx)
JP (4) JP4535678B2 (xx)
KR (2) KR100847417B1 (xx)
CN (3) CN1264578C (xx)
AR (3) AR032400A1 (xx)
AT (2) ATE310044T1 (xx)
AU (3) AU2002249528B2 (xx)
BG (3) BG66420B1 (xx)
BR (3) BRPI0206708B8 (xx)
CA (3) CA2435159C (xx)
CL (1) CL2015003111A1 (xx)
CR (1) CR7034A (xx)
CZ (3) CZ304357B6 (xx)
DE (2) DE60203364T2 (xx)
DK (2) DK1343542T3 (xx)
EA (4) EA006540B1 (xx)
EE (3) EE05678B1 (xx)
EG (2) EG24589A (xx)
ES (2) ES2238569T3 (xx)
HR (1) HRP20030648B1 (xx)
HU (3) HU228810B1 (xx)
IL (6) IL157097A0 (xx)
IS (1) IS6885A (xx)
ME (1) ME00587A (xx)
MX (3) MXPA03006689A (xx)
NO (3) NO327386B1 (xx)
NZ (3) NZ527165A (xx)
PL (3) PL206197B1 (xx)
PT (1) PT1343542E (xx)
RS (1) RS50866B (xx)
SI (2) SI1368419T1 (xx)
SK (3) SK287874B6 (xx)
TW (2) TWI237573B (xx)
UA (1) UA73028C2 (xx)
UY (1) UY27136A1 (xx)
WO (3) WO2002070594A2 (xx)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
CA2504706A1 (en) * 2002-11-04 2004-05-21 Nycomed Danmark Aps Coating of a particulate material with an organic solvent-based coating composition
US20060051340A1 (en) * 2003-01-20 2006-03-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic materials
ATE455563T1 (de) 2003-04-04 2010-02-15 Tissuemed Ltd Zusammensetzungen für die gewebeadhäsion
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
RU2396985C2 (ru) 2004-08-03 2010-08-20 Тиссьюмед Лимитед Материалы, обладающие адгезией к тканям
DK1809343T3 (da) 2004-10-20 2012-11-26 Ethicon Inc Forstærket absorberbar hæmostatisk flerlagssårforbinding samt fremstillingsfremgangsmåde
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
ES2562727T3 (es) 2004-10-20 2016-03-07 Ethicon, Inc. Tejido multicapa absorbible reforzado para su uso en dispositivos médicos y método de fabricación
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
EP2283851B1 (en) 2005-04-25 2023-06-07 Massachusetts Institute of Technology Compositions for promoting hemostasis
JP4864348B2 (ja) * 2005-05-27 2012-02-01 川澄化学工業株式会社 神経再生チューブ
WO2007088402A2 (en) 2006-02-03 2007-08-09 Tissuemed Limited Tissue-adhesive materials
AU2007215382B2 (en) 2006-02-14 2013-11-14 Commonwealth Scientific And Industrial Research Organisation Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
HUE037994T2 (hu) 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
ES2575933T3 (es) 2006-05-31 2016-07-04 Baxter International Inc. Colágeno para su uso en la prevención de la formación de fibrosis epidural después de cirugía espinal
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
MX2009001323A (es) * 2006-08-04 2009-07-22 Stb Lifesaving Technologies In Aposito solido para tratar tejido herido.
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
TWI440664B (zh) * 2007-02-05 2014-06-11 Asahi Kasei E Materials Corp Hydrogen storage alloy and resin composition
CN101053679B (zh) * 2007-04-17 2010-05-26 浙江大学 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法
DE102007037056A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum
DE102007037053A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum für die minimal-invasive Operation
DE102007045066A1 (de) 2007-09-20 2009-04-02 Mike Ehrlich Material zur Blutstillung enthaltend synthetische Peptide oder Polysaccharide
DE102007000574A1 (de) 2007-10-25 2009-04-30 FILK Forschungsinstitut für Leder- und Kunstbahnen gGmbH Biologisch resorbierbares Schwammmaterial und Verfahren zu dessen Herstellung
AR069109A1 (es) 2007-10-30 2009-12-30 Baxter Int Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales
CN101214391B (zh) * 2007-12-27 2010-05-19 广州倍绣生物技术有限公司 一种高效生物胶封闭剂及其应用
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
WO2010002435A2 (en) * 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
CN102802683B (zh) 2009-06-16 2015-11-25 巴克斯特国际公司 止血海绵
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
WO2011072482A1 (en) 2009-12-14 2011-06-23 The University Of Hong Kong Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells
CA2784432C (en) 2009-12-16 2019-01-15 Baxter Healthcare S.A. Hemostatic sponge
WO2011092694A2 (en) 2010-01-28 2011-08-04 Omrix Biopharmaceuticals Ltd. Method for improved fibrin sealing
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
KR101967085B1 (ko) 2010-06-01 2019-04-08 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
KR101865427B1 (ko) 2010-06-01 2018-06-07 백스터 인터내셔널 인코포레이티드 건성의 안정된 지혈 조성물의 제조 방법
EP2596813B1 (en) 2010-07-20 2018-09-05 The Chemo-Sero-Therapeutic Research Institute Sheet preparation for tissue adhesion
MY185054A (en) * 2011-05-24 2021-04-30 Takeda As Rolled collagen carrier
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
US20130041406A1 (en) * 2011-08-10 2013-02-14 Brian W. Bear Surgical staple with localized adjunct coating
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
EP4137164A1 (en) 2011-10-11 2023-02-22 Baxter International Inc. Hemostatic compositions
PH12014500920A1 (en) 2011-10-27 2014-06-09 Baxter Healthcare Sa Hemostatic compositions
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
JP5844894B2 (ja) 2012-05-14 2016-01-20 帝人株式会社 シート成形体および止血材
ES2724233T3 (es) * 2012-05-24 2019-09-09 Takeda As Aparato y proceso para proporcionar un portador de colágeno enrollado
WO2013174879A1 (en) 2012-05-24 2013-11-28 Takeda Nycomed As Packaging
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
ES2706065T3 (es) 2012-07-06 2019-03-27 3 D Matrix Ltd Proceso de llenado-acabado para soluciones de péptidos
DE102013004420A1 (de) 2012-08-20 2014-02-20 Alexander Kopp Stützkörper und Verfahren zu seiner Herstellung
EP2928511B1 (en) * 2012-12-07 2020-04-22 Baxter International Inc. Hemostatic foam
KR101401944B1 (ko) 2012-12-11 2014-05-30 세원셀론텍(주) 콜라겐과 피브린이 혼합된 조직 실란트 및 그 제조방법
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10765774B2 (en) 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
EP3116896B1 (en) 2014-03-10 2018-12-19 3-D Matrix Ltd. Self-assembling peptide compositions
EP3116524B1 (en) 2014-03-10 2018-11-28 3-D Matrix Ltd. Autoassembling peptides for the treatment of pulmonary bulla
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
EP3237041B1 (en) 2014-12-24 2020-01-29 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
CN106730031A (zh) * 2016-12-30 2017-05-31 清华大学 一种用于脊髓损伤修复的仿生纤维蛋白水凝胶束及其制备方法
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
RU2679616C1 (ru) * 2018-07-02 2019-02-12 Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Способ приготовления тромбофибринового сгустка, обладающего ростстимулирующими свойствами
EP3895890B1 (en) * 2018-12-14 2024-07-03 Bmg Incorporated Two-reactant sheet-form tissue-adhesive-reinforcing material
TW202102254A (zh) 2019-03-20 2021-01-16 日商安斯泰來製藥股份有限公司 擔載凝血酶之止血用片材
US20210228765A1 (en) * 2020-01-28 2021-07-29 Becton, Dickinson And Company Self-activating catheter insertion site dressing
CN112225937B (zh) * 2020-10-14 2022-11-01 中山大学 一种温敏型大孔生物水凝胶及其制备方法和应用
CN113117158B (zh) * 2021-03-10 2022-07-26 复旦大学 表面变性蛋白生物功能化修饰的材料及其制备方法和应用
CN114246974B (zh) * 2021-12-24 2023-11-03 中国人民解放军军事科学院军事医学研究院 一种止血贴的制备方法
CN114177346B (zh) * 2021-12-24 2023-05-26 中国人民解放军军事科学院军事医学研究院 一种止血组合物及止血贴与其应用
WO2025023336A1 (ko) * 2023-07-21 2025-01-30 주식회사 덴하우스 지혈용 스펀지
PL447136A1 (pl) * 2023-12-18 2025-06-23 Politechnika Łódzka Sposób wytwarzania wielowarstwowej kompozytowej pianki o podwyższonych właściwościach biologicznych i ograniczonej rozpuszczalności

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1596789A (xx) * 1968-11-27 1970-06-22
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
BR8102435A (pt) * 1981-04-15 1982-11-30 Campos Vidal Benedicto Colageno i microfibrilar e microcristalino para aplicacao em medicina e farmacia
DE3214337C2 (de) * 1982-04-19 1984-04-26 Serapharm - Michael Stroetmann, 4400 Münster Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
US4626286A (en) * 1983-10-31 1986-12-02 Schmid Laboratories, Inc. Collagen gel and the process of making said gel
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
FR2668936B1 (fr) * 1990-11-09 1993-01-15 Eberlin Jean Luc Greffon a base de collagene et de colle de fibrine pour la reconstruction osteo-cartilagineuse et son procede de preparation.
EP0578823B1 (en) * 1991-04-08 2002-01-23 Sumitomo Pharmaceuticals Company, Limited Porous solid preparation containing physiologically active protein substance
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
US6177126B1 (en) * 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
JPH0759812A (ja) * 1993-08-27 1995-03-07 Koken Co Ltd 創傷カバ−材及びその製造方法
AU3463495A (en) * 1994-09-02 1996-03-27 New York Blood Center, Inc., The Production and secretion of recombinant fibrinogen by yeast
WO1997028832A1 (en) * 1996-02-06 1997-08-14 New Generation Medical Corporation Composition for sealing wounds
CA2251475C (en) * 1996-04-04 2006-09-05 Immuno Aktiengesellschaft Hemostatic sponge based on collagen
CA2330972C (en) * 1998-05-01 2008-08-19 Zymogenetics, Inc. Fully recombinant tissue sealant compositions
AU755486B2 (en) * 1998-05-19 2002-12-12 American National Red Cross, The Hemostatic sandwich bandage
WO2000009018A1 (en) * 1998-08-10 2000-02-24 Fibrogen, Inc. Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
WO2000038752A1 (de) * 1998-12-23 2000-07-06 Aventis Behring Gmbh Fibrinklebergranulat und verfahren zu dessen herstellung
DE19922078A1 (de) * 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie

Also Published As

Publication number Publication date
EE05685B1 (et) 2013-12-16
BG108121A (bg) 2004-08-31
AR032517A1 (es) 2003-11-12
PL366932A1 (en) 2005-02-07
WO2002058749A2 (en) 2002-08-01
PL206197B1 (pl) 2010-07-30
SI1368419T1 (sl) 2006-06-30
EP1359947A2 (en) 2003-11-12
ATE310044T1 (de) 2005-12-15
HUP0303896A2 (hu) 2004-03-01
ME00587B (me) 2011-12-20
MXPA03006687A (es) 2004-03-12
NO332462B1 (no) 2012-09-24
BRPI0206709B1 (pt) 2015-09-08
EE200300341A (et) 2003-10-15
WO2002058750A2 (en) 2002-08-01
EP1343542A2 (en) 2003-09-17
DE60207389D1 (de) 2005-12-22
CZ20032198A3 (cs) 2003-12-17
CZ305120B6 (cs) 2015-05-13
CR7034A (es) 2004-03-05
CN1264578C (zh) 2006-07-19
DK1343542T3 (da) 2005-07-25
CA2434964C (en) 2009-04-21
CN1487967A (zh) 2004-04-07
NO20033297D0 (no) 2003-07-22
HRP20030648B1 (en) 2011-10-31
WO2002058749A8 (en) 2004-03-11
PT1343542E (pt) 2005-08-31
JP4535678B2 (ja) 2010-09-01
WO2002070594A8 (en) 2004-03-11
AU2002307809B2 (en) 2007-10-04
CA2434964A1 (en) 2002-08-01
WO2002070594A2 (en) 2002-09-12
DE60207389T2 (de) 2006-08-03
NZ527165A (en) 2005-02-25
DK1368419T3 (da) 2006-04-03
IL157095A0 (en) 2004-02-08
BG66439B1 (bg) 2014-08-29
BRPI0206705B8 (pt) 2021-07-27
BRPI0206709B8 (pt) 2021-06-22
BRPI0206708B8 (pt) 2021-06-22
SK287874B6 (sk) 2012-02-03
EP1343542B1 (en) 2005-03-23
IL157096A (en) 2007-08-19
NZ527166A (en) 2005-03-24
UA73028C2 (uk) 2005-05-16
EG24589A (en) 2009-12-01
PL205181B1 (pl) 2010-03-31
HUP0400768A2 (hu) 2004-07-28
NO20033295D0 (no) 2003-07-22
CA2435159C (en) 2009-07-28
BG108123A (bg) 2004-09-30
CN1246047C (zh) 2006-03-22
HUP0303896A3 (en) 2005-12-28
WO2002070594A3 (en) 2003-01-03
BR0206705A (pt) 2004-02-25
NO327386B1 (no) 2009-06-22
EE200300348A (et) 2003-10-15
EG26417A (en) 2013-10-22
EA006540B1 (ru) 2006-02-24
ES2253523T3 (es) 2006-06-01
EP1368419B1 (en) 2005-11-16
HK1058319A1 (en) 2004-05-14
WO2002058750A3 (en) 2002-10-31
SK10342003A3 (sk) 2004-02-03
IL157097A0 (en) 2004-02-08
BR0206708A (pt) 2004-02-25
SK10352003A3 (sk) 2004-02-03
CN1507358A (zh) 2004-06-23
CL2015003111A1 (es) 2016-07-08
KR20030085522A (ko) 2003-11-05
HUP0303893A2 (hu) 2004-03-01
EE200300349A (et) 2003-10-15
BR0206709A (pt) 2004-02-17
SK288120B6 (sk) 2013-09-03
BRPI0206708B1 (pt) 2015-07-14
EA006700B1 (ru) 2006-02-24
EA005697B1 (ru) 2005-04-28
BR0206705B1 (pt) 2012-08-07
JP4104462B2 (ja) 2008-06-18
AR032800A1 (es) 2003-11-26
NZ527167A (en) 2005-02-25
EE05678B1 (et) 2013-10-15
JP2004521115A (ja) 2004-07-15
DE60203364D1 (de) 2005-04-28
JP2005502733A (ja) 2005-01-27
NO20033296D0 (no) 2003-07-22
NO20033296L (no) 2003-09-25
CA2435425C (en) 2010-07-27
EA200300823A1 (ru) 2004-04-29
AU2002255220B2 (en) 2007-05-31
PL363275A1 (en) 2004-11-15
IL157095A (en) 2009-06-15
EA200401463A1 (ru) 2005-08-25
CZ20032197A3 (cs) 2003-11-12
YU67003A (xx) 2006-05-25
CN1290907C (zh) 2006-12-20
PL206194B1 (pl) 2010-07-30
NO20033295L (no) 2003-09-25
EA200300821A1 (ru) 2004-04-29
WO2002058749A3 (en) 2002-10-10
AU2002249528B2 (en) 2007-03-29
PL363274A1 (en) 2004-11-15
HUP0400768A3 (en) 2006-01-30
JP2004520124A (ja) 2004-07-08
WO2002058750A8 (en) 2004-03-11
EA200300822A1 (ru) 2004-02-26
CZ304357B6 (cs) 2014-03-26
AR032400A1 (es) 2003-11-05
ME00587A (en) 2011-12-20
HU227987B1 (hu) 2012-07-30
NO20033297L (no) 2003-09-25
ATE291445T1 (de) 2005-04-15
DE60203364T2 (de) 2005-09-01
MXPA03006689A (es) 2004-03-12
EP1547626A3 (en) 2009-07-29
HU228810B1 (hu) 2013-05-28
IS6885A (is) 2003-07-24
TWI255726B (en) 2006-06-01
CN1487843A (zh) 2004-04-07
BG66343B1 (bg) 2013-07-31
CA2435159A1 (en) 2002-09-12
EP1368419A2 (en) 2003-12-10
KR100847417B1 (ko) 2008-07-18
HUP0303893A3 (en) 2012-02-28
BG66420B1 (bg) 2014-03-31
JP2007190399A (ja) 2007-08-02
HRP20030648A2 (en) 2005-06-30
CZ20032199A3 (cs) 2003-12-17
IL157097A (en) 2009-12-24
KR100830294B1 (ko) 2008-05-16
IL157096A0 (en) 2004-02-08
BG108122A (bg) 2004-09-30
EP1547626A2 (en) 2005-06-29
TWI237573B (en) 2005-08-11
ES2238569T3 (es) 2005-09-01
RS50866B (sr) 2010-08-31
UY27136A1 (es) 2002-09-30
SI1343542T1 (en) 2005-10-31
EA006686B1 (ru) 2006-02-24
MXPA03006688A (es) 2004-03-12
HK1058371A1 (en) 2004-05-14
SK10362003A3 (sk) 2004-03-02
CA2435425A1 (en) 2002-08-01
KR20030086254A (ko) 2003-11-07

Similar Documents

Publication Publication Date Title
EE05587B1 (et) Meetod kollageenk„sna valmistamiseks
FI20040030L (fi) Menetelmä kumeenin valmistamiseksi
DE60205413D1 (de) Herstellungsverfahren
FI20022087A7 (fi) Menetelmä valmistaa SC-paperia
ITMI20022769A1 (it) Metodo per realizzare un interruttore
FI20010170L (fi) Menetelmä partnerin löytämiseksi
DE60226131D1 (de) Strickverfahren
DE60103427D1 (de) Übereinstimmungssteuerverfahren
DE60237746D1 (de) Filmherstellungsmethode
FI20011541L (fi) Menetelmä massan valmistamiseksi
FI20012271L (fi) Menetelmä vastinpisteiden määrittämiseksi
FI20002824L (fi) Menetelmä puhelun muodostamiseksi
FI20010370L (fi) Menetelmä monitavoitteisen ongelman ratkaisemiseksi
FI20002875A0 (fi) Menetelmä linkkiadaptaation suorittamiseksi
HUP0302467A3 (en) Method for producing sulfonamide substituted imidazotriazinones
FI20000369L (fi) Menetelmä kefalokuvauksen suorittamiseksi
NO20032227L (no) En laktoniseringsfremgangsmåte
FI20001480L (fi) Menetelmä merkinnän tekemiseksi
DE60226093D1 (de) Urmedium-Reinigungsmethode
FI20010525A7 (fi) Menetelmä tiedon pakkaamiseksi
FI20010180L (fi) Menetelmä valmistusprosessien kuvaamiseksi
FI20001328L (fi) Menetelmä monitoimisen entsyymin tuottamiseksi
SE0104471D0 (sv) New method
FI20011169L (fi) Menetelmä petun modifioimiseksi
SE0103416D0 (sv) New method

Legal Events

Date Code Title Description
HC1A Change of owner name
HC1A Change of owner name